Cargando…

HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies

OBJECTIVE: The aim of this study is to describe the prevalence of HPV types in invasive cervical cancers in Italy from 1996 to 2008. METHODS: A pooled analysis of the three largest case series typed to date was performed. HPV typing was performed on paraffin-embedded slices. Molecular analyses were...

Descripción completa

Detalles Bibliográficos
Autores principales: Giorgi Rossi, Paolo, Sideri, Mario, Carozzi, Francesca Maria, Vocaturo, Amina, Buonaguro, Franco Maria, Tornesello, Maria Lina, Burroni, Elena, Mariani, Luciano, Boveri, Sara, Zaffina, Leandra Maria, Chini, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527181/
https://www.ncbi.nlm.nih.gov/pubmed/23110797
http://dx.doi.org/10.1186/1750-9378-7-26
_version_ 1782253668810096640
author Giorgi Rossi, Paolo
Sideri, Mario
Carozzi, Francesca Maria
Vocaturo, Amina
Buonaguro, Franco Maria
Tornesello, Maria Lina
Burroni, Elena
Mariani, Luciano
Boveri, Sara
Zaffina, Leandra Maria
Chini, Francesco
author_facet Giorgi Rossi, Paolo
Sideri, Mario
Carozzi, Francesca Maria
Vocaturo, Amina
Buonaguro, Franco Maria
Tornesello, Maria Lina
Burroni, Elena
Mariani, Luciano
Boveri, Sara
Zaffina, Leandra Maria
Chini, Francesco
author_sort Giorgi Rossi, Paolo
collection PubMed
description OBJECTIVE: The aim of this study is to describe the prevalence of HPV types in invasive cervical cancers in Italy from 1996 to 2008. METHODS: A pooled analysis of the three largest case series typed to date was performed. HPV typing was performed on paraffin-embedded slices. Molecular analyses were performed in four laboratories. Multivariate analyses were performed to test the associations between calendar time, age, and geographical area and the proportion of types 16/18. RESULTS: Out of 574 cancers, 24 (4.2%) were HPV negative. HPV 16 and 18 were responsible for 74.4% (378/508) and 80.3% (49/61) of the squamous cancers and adenocarcinomas, respectively. Other frequent types were 31 (9.5%), 45 (6.4%), and 58 (3.3%) for squamous cancers and 45 (13.3%), 31, 35, and 58 (5.0%) for adenocarcinomas. The proportion of HPV 16 and/or 18 decreased with age (p-value for trend <0.03), while it increased in cancers diagnosed in more recent years (p-value for trend < 0.005). CONCLUSIONS: The impact of HPV 16/18 vaccine on cervical cancer will be greater for early onset cancers. In vaccinated women, screening could be started at an older age without reducing protection.
format Online
Article
Text
id pubmed-3527181
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35271812012-12-21 HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies Giorgi Rossi, Paolo Sideri, Mario Carozzi, Francesca Maria Vocaturo, Amina Buonaguro, Franco Maria Tornesello, Maria Lina Burroni, Elena Mariani, Luciano Boveri, Sara Zaffina, Leandra Maria Chini, Francesco Infect Agent Cancer Research Article OBJECTIVE: The aim of this study is to describe the prevalence of HPV types in invasive cervical cancers in Italy from 1996 to 2008. METHODS: A pooled analysis of the three largest case series typed to date was performed. HPV typing was performed on paraffin-embedded slices. Molecular analyses were performed in four laboratories. Multivariate analyses were performed to test the associations between calendar time, age, and geographical area and the proportion of types 16/18. RESULTS: Out of 574 cancers, 24 (4.2%) were HPV negative. HPV 16 and 18 were responsible for 74.4% (378/508) and 80.3% (49/61) of the squamous cancers and adenocarcinomas, respectively. Other frequent types were 31 (9.5%), 45 (6.4%), and 58 (3.3%) for squamous cancers and 45 (13.3%), 31, 35, and 58 (5.0%) for adenocarcinomas. The proportion of HPV 16 and/or 18 decreased with age (p-value for trend <0.03), while it increased in cancers diagnosed in more recent years (p-value for trend < 0.005). CONCLUSIONS: The impact of HPV 16/18 vaccine on cervical cancer will be greater for early onset cancers. In vaccinated women, screening could be started at an older age without reducing protection. BioMed Central 2012-10-12 /pmc/articles/PMC3527181/ /pubmed/23110797 http://dx.doi.org/10.1186/1750-9378-7-26 Text en Copyright ©2012 Giorgi Rossi et al.; licensee Biomed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Giorgi Rossi, Paolo
Sideri, Mario
Carozzi, Francesca Maria
Vocaturo, Amina
Buonaguro, Franco Maria
Tornesello, Maria Lina
Burroni, Elena
Mariani, Luciano
Boveri, Sara
Zaffina, Leandra Maria
Chini, Francesco
HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
title HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
title_full HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
title_fullStr HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
title_full_unstemmed HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
title_short HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies
title_sort hpv type distribution in invasive cervical cancers in italy: pooled analysis of three large studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527181/
https://www.ncbi.nlm.nih.gov/pubmed/23110797
http://dx.doi.org/10.1186/1750-9378-7-26
work_keys_str_mv AT giorgirossipaolo hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies
AT siderimario hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies
AT carozzifrancescamaria hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies
AT vocaturoamina hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies
AT buonagurofrancomaria hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies
AT tornesellomarialina hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies
AT burronielena hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies
AT marianiluciano hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies
AT boverisara hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies
AT zaffinaleandramaria hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies
AT chinifrancesco hpvtypedistributionininvasivecervicalcancersinitalypooledanalysisofthreelargestudies